RaySearch partners with Heidelberg University Hospital on RayCare OIS

Press releases may be edited for formatting or style | April 20, 2018 Rad Oncology Radiation Therapy

About Heidelberg University Hospital

Heidelberg University is the oldest university in Germany; its first medical lectures were held here in 1388. Today, Heidelberg University Hospital is one of the largest and most prestigious medical centers in Europe, with a reputation based on excellent patient care, research and teaching. Heidelberg University Hospital offers inpatients and outpatients an innovative and effective diagnosis and therapy for all complex diseases. Modern buildings with state-of-the-art equipment delivers medical care to the highest international standards. The proximity and interlinking of the specialist departments benefit the patient, with interdisciplinary cooperation ensuring optimal treatment.

About RayCare

RayCare represents the future of OIS technology, developed from the ground up by RaySearch to support the complex logistical challenges of modern, large-scale radiation therapy centers. RayCare will integrate the high-performance radiation therapy algorithms available in RayStation with advanced features for clinical resource optimization, workflow automation and adaptive radiation therapy.

About RaySearch

RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation® treatment planning system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. The company has now launched the next-generation oncology information system, RayCare™, which comprises a new product area for RaySearch. RaySearch's software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since November 2003.

* Subject to regulatory clearance in some markets.

HIT-Cision LinkedIn 002

SOURCE RaySearch Laboratories

Back to HCB News

You Must Be Logged In To Post A Comment